AbbVie Inc Partners with Chicago Cubs on Cancer Advocacy Campaign
AbbVie Inc, a biotechnology company specializing in pharmaceutical products, has partnered with the Chicago Cubs on a campaign called “Striking Out Cancer” to support cancer advocacy and non-profit organizations.
The partnership is part of AbbVie’s efforts to make a positive impact in the community. Details of the campaign include:
- Support for cancer advocacy and non-profit organizations
- Collaboration with the Chicago Cubs to raise awareness and funds for cancer research
In terms of stock performance, AbbVie’s price has been relatively stable, with a 12-month average price of $155.67 as of March 2023. However, some analysts have lowered their price targets, indicating a slight decrease in investor confidence.
Key analyst price targets for AbbVie Inc as of March 2023:
- Morgan Stanley: $140.00
- Goldman Sachs: $145.00
- J.P. Morgan: $150.00
Despite this, the company remains a strong player in the pharmaceutical industry, with a market capitalization of $245.4 billion as of March 2023.